celecoxib has been researched along with Pregnancy in 46 studies
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effectiveness of celecoxib for pain relief and antipyresis during second trimester abortion using sublingual misoprostol." | 9.27 | Effectiveness of celecoxib for pain relief and antipyresis in second trimester medical abortions with misoprostol: a randomized controlled trial. ( Choobun, T; Tintara, H; Voradithi, P, 2018) |
| "Celecoxib administration for more than 48 hours in the second trimester of pregnancy might be safe and tolerable in terms of fetal PSV-DA and amniotic fluid volume as long as careful ultrasound monitoring is performed." | 8.12 | The effect of celecoxib for treatment of preterm labor on fetuses during the second trimester of pregnancy: A pilot case series. ( Chigusa, Y; Kawasaki, K; Kondoh, E; Mandai, M; Mogami, H; Ohtsuki, M; Ueda, A; Yamaguchi, K, 2022) |
| " The objective of the present study was to examine whether celecoxib, a selective COX-2 inhibitor, can reduce systemic LPS-induced brain inflammation and brain damage." | 7.79 | Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation and white matter injury in the neonatal rats. ( Bhatt, AJ; Cai, Z; Fan, LW; Kaizaki, A; Numazawa, S; Pang, Y; Tanaka, S; Tien, LT, 2013) |
| " Timing of administration, inadequate dosing and possible altered pharmacokinetics in pregnancy may explain the lack of efficacy." | 6.71 | The effect of celecoxib on intrathecal morphine-induced pruritus in patients undergoing Caesarean section. ( Irwin, MG; Lee, LH; Lim, J; Wong, CK, 2004) |
| " Indomethacin was superior to celecoxib for pain score at rest at 8-12 h and celecoxib + parecoxib, diclofenac, and ketorolac for pain score on movement at 48 h." | 5.41 | Comparison of different nonsteroidal anti-inflammatory drugs for cesarean section: a systematic review and network meta-analysis. ( Blake, L; Carvalho, B; Carver, AL; Desai, N; Murdoch, I; O'Carroll, JE; Onwochei, DN; Sultan, P, 2023) |
| "To evaluate the effectiveness of celecoxib for pain relief and antipyresis during second trimester abortion using sublingual misoprostol." | 5.27 | Effectiveness of celecoxib for pain relief and antipyresis in second trimester medical abortions with misoprostol: a randomized controlled trial. ( Choobun, T; Tintara, H; Voradithi, P, 2018) |
| " Both celecoxib and valdecoxib are indicated for the treatment of primary dysmenorrhea, and may be effective in postoperative pain, including hysterectomy, and pain associated with endometriosis." | 4.81 | COX-2 inhibitors and their role in gynecology. ( Hayes, EC; Rock, JA, 2002) |
| "Celecoxib administration for more than 48 hours in the second trimester of pregnancy might be safe and tolerable in terms of fetal PSV-DA and amniotic fluid volume as long as careful ultrasound monitoring is performed." | 4.12 | The effect of celecoxib for treatment of preterm labor on fetuses during the second trimester of pregnancy: A pilot case series. ( Chigusa, Y; Kawasaki, K; Kondoh, E; Mandai, M; Mogami, H; Ohtsuki, M; Ueda, A; Yamaguchi, K, 2022) |
| " The objective of the present study was to examine whether celecoxib, a selective COX-2 inhibitor, can reduce systemic LPS-induced brain inflammation and brain damage." | 3.79 | Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation and white matter injury in the neonatal rats. ( Bhatt, AJ; Cai, Z; Fan, LW; Kaizaki, A; Numazawa, S; Pang, Y; Tanaka, S; Tien, LT, 2013) |
| " The objective of the current study was to examine whether celecoxib, a selective COX-2 inhibitor, could ameliorate lipopolysaccharide (LPS)-induced brain inflammation, dopaminergic neuronal dysfunction and sensorimotor behavioral impairments." | 3.79 | Celecoxib reduces brain dopaminergic neuronaldysfunction, and improves sensorimotor behavioral performance in neonatal rats exposed to systemic lipopolysaccharide. ( Bhatt, AJ; Cai, Z; Fan, LW; Kaizaki, A; Numazawa, S; Pang, Y; Tanaka, S; Tien, LT, 2013) |
| "To analyse the expression of 15 genes encoding receptors and enzymes associated with the molecular mechanism of the tocolytic drugs atosiban (oxytocin receptor antagonist), nifedipine (calcium channel blocker) and celecoxib (selective cyclo-oxygenase-2 inhibitor) in preterm labor patients with premature rupture of fetal membranes in relation to symptoms of intrauterine infection and preterm labor risk factors." | 3.78 | Expression of selected genes in preterm premature rupture of fetal membranes. ( Chyczewski, L; Kowalczuk, O; Kuć, P; Laudański, P; Laudański, T, 2012) |
| " Strikingly, uterine deletion of Trp53 increased the incidence of preterm birth, a condition that was corrected by oral administration of the selective COX2 inhibitor celecoxib." | 3.76 | Uterine-specific p53 deficiency confers premature uterine senescence and promotes preterm birth in mice. ( Bradshaw, HB; Daikoku, T; Dey, SK; Hirota, Y; Tranguch, S; Xie, H, 2010) |
| "To evaluate the molecular responses of vascular endothelial growth factor (VEGF) and its receptors to dexamethasone (Dex) and celecoxib (Cel) during hyperoxia and during hyperoxia followed by recovery in room air, in newborn rabbit retinas." | 3.71 | Regulation of retinal vascular endothelial growth factor and receptors in rabbits exposed to hyperoxia. ( Akmal, Y; Ang, JG; Beharry, KD; Modanlou, HD; Nishihara, KC; Ozaki, NK; Sheikh, R, 2002) |
| "We aimed to use celecoxib to suppress preterm labor instead magnesium sulfate (MgSO4) to prevent preterm labor." | 2.79 | Using celecoxib for the suppression of preterm labor instead of magnesium sulfate. ( Cheraghi, M; Moramezi, F; Saadati, N; Sokhray, L, 2014) |
| "Celecoxib was associated with a slightly lower VAS pain score at rest and less upper gastrointestinal symptoms were reported when compared to diclofenac." | 2.73 | Oral celecoxib versus oral diclofenac for post-perineal repair analgesia after spontaneous vaginal birth: a randomised trial. ( Lim, SS; Omar, SZ; Sockalingam, JK; Tan, PC, 2008) |
| " Timing of administration, inadequate dosing and possible altered pharmacokinetics in pregnancy may explain the lack of efficacy." | 2.71 | The effect of celecoxib on intrathecal morphine-induced pruritus in patients undergoing Caesarean section. ( Irwin, MG; Lee, LH; Lim, J; Wong, CK, 2004) |
| " There were no significant maternal or neonatal adverse events." | 2.70 | A prospective randomized safety trial of celecoxib for treatment of preterm labor. ( Bernhard, LM; Gerber, S; Gross, GA; Leguizamon, G; Levy, R; Mathur, A; Nelson, DM; Sadovsky, Y; Stika, CS, 2002) |
| " RATIONALE FOR THE USE OF SELECTIVE COX-2 INHIBITORS: The rationale for the prescription of selective COX-2 inhibitors as neuroprotective drugs in AD lies on: Epidemiological data having shown a reduced risk of developing AD in patients treated with anti-inflammatory doses of classical NSAIDs (inhibition of COX-1 and COX-2) but not with antithrombotic doses of aspirin (selective inhibition of COX-1), Cellular experiments, Demonstration of a better gastro-intestinal (GI) safety profile with selective COX-2 inhibitors than with classical NSAIDs in short-term studies, allowing a possible long-term use in AD." | 2.41 | [Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives]. ( Blain, A; Blain, H; Jeandel, C; Jouzeau, JY; Netter, P; Terlain, B; Touchon, J; Tréchot, P, 2000) |
| " Celecoxib is metabolised primarily by the cytochrome P450 (CYP) 2C9 isoenzyme and has an elimination half-life of about 11 hours in healthy individuals." | 2.41 | Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor. ( Davies, NM; Day, RO; McLachlan, AJ; Williams, KM, 2000) |
| "· ERAS protocols improve postoperative pain control and lower postoperative opioid use." | 1.72 | Enhanced Recovery after Surgery Protocol to Improve Racial and Ethnic Disparities in Postcesarean Pain Management. ( Berghella, V; Cao, CD; Dayaratna, S; Felder, L; Konys, C; Mercier, R; Weerasooriya, N, 2022) |
| "Treatment with curcumin significantly could attenuate the celecoxib-induced deficits in proliferation through activating the Wnt/β-Catenin pathway." | 1.46 | Celecoxib-induced inhibition of neurogenesis in fetal frontal cortex is attenuated by curcumin via Wnt/β-catenin pathway. ( Liu, J; Sun, K; Tian, S; Wang, R; Wang, Y; Yang, X, 2017) |
| "Placentas from women with and without preeclampsia were collected." | 1.42 | Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1. ( Li, C; Raikwar, NS; Santillan, DA; Santillan, MK; Thomas, CP, 2015) |
| "Furthermore, breast cancer cells exposed to the involuting mammary microenvironment acquired prolymphangiogenic properties that contributed to peritumor lymphatic expansion, tumor size, invasion, and distant metastases." | 1.40 | Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer. ( Betts, CB; Borges, VF; Guo, Q; Jindal, S; Kapoor, P; Lyons, TR; Martinson, HA; Schedin, P, 2014) |
| "The prognosis of breast cancer in young women is influenced by reproductive history." | 1.37 | Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. ( Borges, VF; Conklin, MW; Eliceiri, KW; Keely, PJ; Lyons, TR; Marusyk, A; O'Brien, J; Schedin, P; Tan, AC, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.35) | 18.2507 |
| 2000's | 22 (47.83) | 29.6817 |
| 2010's | 14 (30.43) | 24.3611 |
| 2020's | 8 (17.39) | 2.80 |
| Authors | Studies |
|---|---|
| Felder, L | 1 |
| Cao, CD | 1 |
| Konys, C | 1 |
| Weerasooriya, N | 1 |
| Mercier, R | 1 |
| Berghella, V | 1 |
| Dayaratna, S | 1 |
| Ohtsuki, M | 1 |
| Chigusa, Y | 1 |
| Mogami, H | 1 |
| Ueda, A | 1 |
| Kawasaki, K | 1 |
| Yamaguchi, K | 1 |
| Mandai, M | 1 |
| Kondoh, E | 1 |
| Zhao, Q | 1 |
| Dai, W | 1 |
| Chen, HY | 1 |
| Jacobs, RE | 1 |
| Zlokovic, BV | 1 |
| Lund, BT | 1 |
| Montagne, A | 1 |
| Bonnin, A | 1 |
| Ali, MA | 2 |
| Abdelhady, SA | 2 |
| Yacout, DM | 2 |
| Kandil, LS | 2 |
| Elblehi, SS | 1 |
| El-Mas, MM | 2 |
| Murdoch, I | 1 |
| Carver, AL | 1 |
| Sultan, P | 1 |
| O'Carroll, JE | 1 |
| Blake, L | 1 |
| Carvalho, B | 1 |
| Onwochei, DN | 1 |
| Desai, N | 1 |
| Essawy, MM | 1 |
| Latif, D | 1 |
| Darweesh, FF | 1 |
| Osman, OM | 1 |
| Abdelhakim, AM | 1 |
| Nabil, H | 1 |
| Ashour, ASA | 1 |
| Yu, Y | 1 |
| Gao, S | 1 |
| Yuen, VM | 1 |
| Choi, SW | 1 |
| Xu, X | 2 |
| Wang, R | 1 |
| Tian, S | 1 |
| Yang, X | 1 |
| Liu, J | 1 |
| Wang, Y | 1 |
| Sun, K | 1 |
| Tintara, H | 1 |
| Voradithi, P | 1 |
| Choobun, T | 1 |
| Reijnders, D | 1 |
| Liu, CC | 1 |
| Zhao, AM | 1 |
| Olson, KN | 1 |
| Butler, SD | 1 |
| Douglas, NC | 1 |
| Sones, JL | 1 |
| Fan, LW | 2 |
| Kaizaki, A | 2 |
| Tien, LT | 2 |
| Pang, Y | 2 |
| Tanaka, S | 2 |
| Numazawa, S | 2 |
| Bhatt, AJ | 2 |
| Cai, Z | 2 |
| Cha, J | 1 |
| Bartos, A | 1 |
| Egashira, M | 1 |
| Haraguchi, H | 1 |
| Saito-Fujita, T | 1 |
| Leishman, E | 1 |
| Bradshaw, H | 1 |
| Dey, SK | 3 |
| Hirota, Y | 2 |
| Paech, MJ | 1 |
| McDonnell, NJ | 1 |
| Sinha, A | 1 |
| Baber, C | 1 |
| Nathan, EA | 1 |
| Zavitsanou, K | 1 |
| Lim, CK | 1 |
| Purves-Tyson, T | 1 |
| Karl, T | 1 |
| Kassiou, M | 1 |
| Banister, SD | 1 |
| Guillemin, GJ | 1 |
| Weickert, CS | 1 |
| Lyons, TR | 2 |
| Borges, VF | 2 |
| Betts, CB | 1 |
| Guo, Q | 1 |
| Kapoor, P | 1 |
| Martinson, HA | 1 |
| Jindal, S | 1 |
| Schedin, P | 2 |
| Saadati, N | 1 |
| Moramezi, F | 1 |
| Cheraghi, M | 1 |
| Sokhray, L | 1 |
| Li, C | 1 |
| Raikwar, NS | 1 |
| Santillan, MK | 1 |
| Santillan, DA | 1 |
| Thomas, CP | 1 |
| Daikoku, T | 1 |
| Tranguch, S | 1 |
| Xie, H | 1 |
| Bradshaw, HB | 1 |
| O'Brien, J | 1 |
| Conklin, MW | 1 |
| Keely, PJ | 1 |
| Eliceiri, KW | 1 |
| Marusyk, A | 1 |
| Tan, AC | 1 |
| Kuć, P | 1 |
| Laudański, P | 1 |
| Kowalczuk, O | 1 |
| Chyczewski, L | 1 |
| Laudański, T | 1 |
| Stika, CS | 1 |
| Gross, GA | 1 |
| Leguizamon, G | 1 |
| Gerber, S | 1 |
| Levy, R | 1 |
| Mathur, A | 1 |
| Bernhard, LM | 1 |
| Nelson, DM | 1 |
| Sadovsky, Y | 1 |
| Kajino, H | 1 |
| Roman, C | 2 |
| Clyman, RI | 2 |
| Hayes, EC | 1 |
| Rock, JA | 1 |
| Hausman, N | 4 |
| Beharry, K | 2 |
| Nishihara, K | 2 |
| Akmal, Y | 4 |
| Asrat, T | 4 |
| Beharry, KD | 3 |
| Nishihara, KC | 2 |
| Stavitsky, Y | 2 |
| Shafiq, N | 1 |
| Malhotra, S | 1 |
| Pandhi, P | 1 |
| Kammerer, S | 1 |
| Chan, VS | 1 |
| Lee, LH | 1 |
| Irwin, MG | 1 |
| Lim, J | 1 |
| Wong, CK | 1 |
| Hartleroad, JY | 1 |
| Modanlou, HD | 2 |
| Borna, S | 1 |
| Saeidi, FM | 1 |
| Lim, SS | 1 |
| Tan, PC | 1 |
| Sockalingam, JK | 1 |
| Omar, SZ | 1 |
| Rodgers, E | 1 |
| Blain, H | 1 |
| Jouzeau, JY | 1 |
| Blain, A | 1 |
| Terlain, B | 1 |
| Tréchot, P | 1 |
| Touchon, J | 1 |
| Netter, P | 1 |
| Jeandel, C | 1 |
| Davies, NM | 1 |
| McLachlan, AJ | 1 |
| Day, RO | 1 |
| Williams, KM | 1 |
| Jeske, AH | 1 |
| Takahashi, Y | 1 |
| Chemtob, S | 1 |
| Tse, MM | 1 |
| Lin, E | 1 |
| Heymann, MA | 1 |
| Sakai, M | 1 |
| Tanebe, K | 1 |
| Sasaki, Y | 1 |
| Momma, K | 1 |
| Yoneda, S | 1 |
| Saito, S | 1 |
| Reese, J | 1 |
| Zhao, X | 1 |
| Ma, WG | 1 |
| Brown, N | 1 |
| Maziasz, TJ | 1 |
| Slattery, MM | 1 |
| Friel, AM | 1 |
| Healy, DG | 1 |
| Morrison, JJ | 1 |
| Ozaki, NK | 1 |
| Ang, JG | 1 |
| Sheikh, R | 1 |
| Sookvanichsilp, N | 1 |
| Pulbutr, P | 1 |
7 reviews available for celecoxib and Pregnancy
| Article | Year |
|---|---|
Comparison of different nonsteroidal anti-inflammatory drugs for cesarean section: a systematic review and network meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cesarean Section; Diclofenac; Female; Humans; In | 2023 |
COX-2 inhibitors and their role in gynecology.
Topics: Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Administra | 2002 |
A mechanistic perspective on the specificity and extent of COX-2 inhibition in pregnancy.
Topics: Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Etoricoxib; Fem | 2004 |
Treating pain with COX-2 inhibitors.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Drug Costs; Drug Inte | 1999 |
[Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives].
Topics: Adult; Age Factors; Aged; Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain | 2000 |
Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Biotransform | 2000 |
COX-2 inhibitors and dental pain control.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Contraindications; Cyclooxygenase Inhibitors; Fa | 1999 |
10 trials available for celecoxib and Pregnancy
| Article | Year |
|---|---|
Oral tramadol versus oral celecoxib for analgesia after mediolateral episiotomy repair in obese primigravidae: a randomized controlled trial.
Topics: Analgesia; Analgesics, Opioid; Celecoxib; Double-Blind Method; Episiotomy; Female; Humans; Obesity; | 2021 |
The analgesic efficacy of ultrasound-guided transversus abdominis plane (TAP) block combined with oral multimodal analgesia in comparison with oral multimodal analgesia after caesarean delivery: a randomized controlled trial.
Topics: Abdominal Muscles; Acetaminophen; Administration, Oral; Adult; Analgesia, Obstetrical; Analgesics; C | 2021 |
Effectiveness of celecoxib for pain relief and antipyresis in second trimester medical abortions with misoprostol: a randomized controlled trial.
Topics: Abortion, Therapeutic; Administration, Sublingual; Adult; Anti-Inflammatory Agents, Non-Steroidal; A | 2018 |
A randomised controlled trial of parecoxib, celecoxib and paracetamol as adjuncts to patient-controlled epidural analgesia after caesarean delivery.
Topics: Acetaminophen; Adult; Analgesia, Epidural; Analgesia, Obstetrical; Analgesia, Patient-Controlled; An | 2014 |
Using celecoxib for the suppression of preterm labor instead of magnesium sulfate.
Topics: Adult; Celecoxib; Female; Gestational Age; Humans; Magnesium Sulfate; Obstetric Labor, Premature; Pa | 2014 |
A prospective randomized safety trial of celecoxib for treatment of preterm labor.
Topics: Adolescent; Adult; Celecoxib; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Humans; Indome | 2002 |
The effect of celecoxib on intrathecal morphine-induced pruritus in patients undergoing Caesarean section.
Topics: Adult; Analgesics, Opioid; Anesthesia, Obstetrical; Anesthesia, Spinal; Antipruritics; Celecoxib; Ce | 2004 |
Celecoxib versus magnesium sulfate to arrest preterm labor: randomized trial.
Topics: Adult; Birth Weight; Celecoxib; Cyclooxygenase 2 Inhibitors; Female; Gestational Age; Humans; Infant | 2007 |
Oral celecoxib versus oral diclofenac for post-perineal repair analgesia after spontaneous vaginal birth: a randomised trial.
Topics: Administration, Oral; Adult; Analgesia; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Delivery | 2008 |
Uterine relaxant effects of cyclooxygenase-2 inhibitors in vitro.
Topics: Adult; Celecoxib; Cesarean Section; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase In | 2001 |
29 other studies available for celecoxib and Pregnancy
| Article | Year |
|---|---|
Enhanced Recovery after Surgery Protocol to Improve Racial and Ethnic Disparities in Postcesarean Pain Management.
Topics: Acetaminophen; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents; Celecoxib; Endrin; Enhanced | 2022 |
The effect of celecoxib for treatment of preterm labor on fetuses during the second trimester of pregnancy: A pilot case series.
Topics: Celecoxib; Cyclooxygenase 2 Inhibitors; Ductus Arteriosus; Female; Humans; Infant; Infant, Newborn; | 2022 |
Prenatal disruption of blood-brain barrier formation via cyclooxygenase activation leads to lifelong brain inflammation.
Topics: Animals; Blood-Brain Barrier; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Encephalitis | 2022 |
Gestational NSAIDs distinctly reprogram cardiac injury in preeclamptic rats: Roles of cyclooxygenase, apoptotic and autophagic trails.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhi | 2022 |
The suppression of MAPK/NOX/MMP signaling prompts renoprotection conferred by prenatal naproxen in weaning preeclamptic rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Diclofenac; Female; Humans; Naproxen; P | 2023 |
Celecoxib-induced inhibition of neurogenesis in fetal frontal cortex is attenuated by curcumin via Wnt/β-catenin pathway.
Topics: Animals; Animals, Newborn; Brain; Celecoxib; Cell Differentiation; Cell Proliferation; Cells, Cultur | 2017 |
Celecoxib restores angiogenic factor expression at the maternal-fetal interface in the BPH/5 mouse model of preeclampsia.
Topics: Angiogenesis Inducing Agents; Animals; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease Models, Anima | 2018 |
Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation and white matter injury in the neonatal rats.
Topics: Age Factors; Animals; Animals, Newborn; Brain; Calcium-Binding Proteins; Celecoxib; Cell Death; Cycl | 2013 |
Celecoxib reduces brain dopaminergic neuronaldysfunction, and improves sensorimotor behavioral performance in neonatal rats exposed to systemic lipopolysaccharide.
Topics: Animals; Animals, Newborn; Blotting, Western; Celecoxib; Cyclooxygenase 2 Inhibitors; Dopaminergic N | 2013 |
Combinatory approaches prevent preterm birth profoundly exacerbated by gene-environment interactions.
Topics: 20-Hydroxysteroid Dehydrogenases; Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; | 2013 |
Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: amelioration by COX-2 inhibition.
Topics: Animals; Brain; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dizocilpine Maleate; | 2014 |
Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer.
Topics: Animals; Breast Neoplasms; Celecoxib; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Female | 2014 |
Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Cell Hypoxia; Cell Line | 2015 |
Uterine-specific p53 deficiency confers premature uterine senescence and promotes preterm birth in mice.
Topics: Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Decidua; Dinoprost; Embryo Implan | 2010 |
Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2.
Topics: Analysis of Variance; Animals; Blotting, Western; Breast Neoplasms; Carcinoma, Ductal; Celecoxib; Ce | 2011 |
Expression of selected genes in preterm premature rupture of fetal membranes.
Topics: Adult; Calcium Channel Blockers; Calcium Channels, L-Type; Celecoxib; Cyclooxygenase 2 Inhibitors; D | 2012 |
Renal effects of cyclooxygenase-2 inhibition in fetal lambs.
Topics: Animals; Arteries; Body Water; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygen | 2002 |
Antenatal administration of celecoxib, a selective cyclooxygenase (COX)-2 inhibitor, appears to improve placental perfusion in the pregnant rabbit.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Body Weight; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 In | 2003 |
Effect of the antenatal administration of celecoxib during the second and third trimesters of pregnancy on prostaglandin, cytokine, and nitric oxide levels in rabbits.
Topics: Animals; Celecoxib; Cyclooxygenase Inhibitors; Cytokines; Drug Administration Schedule; Female; Mode | 2003 |
Response of fetal prostanoids, nitric oxide, and ductus arteriosus to the short- and long-term antenatal administration of celecoxib, a selective cyclo-oxygenase-2 inhibitor, in the pregnant rabbit.
Topics: Analysis of Variance; Animals; Celecoxib; Cyclooxygenase Inhibitors; Drug Administration Schedule; D | 2003 |
Comparison of nonselective cyclo-oxygenase (COX) inhibitor and selective COX-2 inhibitors on preimplantation loss, postimplantation loss and duration of gestation: an experimental study.
Topics: Animals; Celecoxib; Cyclooxygenase Inhibitors; Embryonic Development; Female; Gestational Age; Indom | 2004 |
[New prevention strategies against breast cancer and cervical carcinoma. What can you advice to your patients].
Topics: Adolescent; Adult; Age Factors; Anastrozole; Anticarcinogenic Agents; Breast Neoplasms; Celecoxib; C | 2003 |
Effect of maternal administration of selective cyclooxygenase (COX)-2 inhibitors on renal size, growth factors, proteinases, and COX-2 secretion in the fetal rabbit.
Topics: Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female | 2005 |
Cyclooxygenase-2 inhibitors constrict the fetal lamb ductus arteriosus both in vitro and in vivo.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase | 2000 |
Evaluation of the tocolytic effect of a selective cyclooxygenase-2 inhibitor in a mouse model of lipopolysaccharide-induced preterm delivery.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chorioamnionitis; Cyclooxygenase 2; Cyc | 2001 |
Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice.
Topics: Animals; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase | 2001 |
Cutaneous drug reaction case reports: from the world literature.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Bupropion; Celecoxib; Chlorquinaldol; Cytarabi | 2002 |
Regulation of retinal vascular endothelial growth factor and receptors in rabbits exposed to hyperoxia.
Topics: Animals; Animals, Newborn; Celecoxib; Cyclooxygenase Inhibitors; Dexamethasone; Endothelial Growth F | 2002 |
Anti-implantation effects of indomethacin and celecoxib in rats.
Topics: Animals; Celecoxib; Contraception; Contraceptives, Postcoital; Cyclooxygenase Inhibitors; Decidua; E | 2002 |